Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIET study of pazopanib taken with breakfast to improve tolerability
NL-OMON47219Active, not recruiting
- Sponsor
- Apotheek
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pazopanib in renal cell carcinoma (RCC) and soft tissue sarcoma (STS), sponsored by Apotheek. Started Jun 2014; status: active, not recruiting.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NL-OMON47219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47219.